Business

AlleAktien publishes new study: with details on Johnson & Johnson's Kenvue deal.

AlleAktien provides important insights into the Kenvue deal, essential for Johnson & Johnson shareholders in upcoming decisions.

Eulerpool News Dec 1, 2023, 3:33 PM

In a new development in the financial market, AlleAktien, a leading provider of stock analysis, has published its comprehensive study "Insights into the Kenvue Deal: What Johnson & Johnson Shareholders Need to Know Now." The analysis sheds light on the recent spin-off of Johnson & Johnson's consumer health division into the standalone company Kenvue and provides important insights for shareholders of both companies.

According to AlleAktien, the Kenvue deal is a significant change for Johnson & Johnson investors. With a revenue of around $15 billion and a profit of $1.5 billion last year, Johnson & Johnson's Consumer Health division, now known as Kenvue, is considered a strong business unit. The successful IPO in May, in which 10% of the shares were sold for $4.3 billion, demonstrates the financial viability of the newly formed company.

The analysis continues to discuss the initial market reaction, with Kenvue's stock price rising from $22 to $27.50, but later stabilizing around $24.40. AlleAktien emphasizes that this price development and the overall performance of the company are important factors for investment decisions.

The study by AlleAktien aims to help Johnson & Johnson shareholders make an informed decision about the offer to exchange their shares for Kenvue stock. "This analysis is crucial in understanding the pros and cons of the Kenvue deal and how it could impact an investor's portfolio," explains Michael C. Jakob, CEO of AlleAktien.

Interested readers and investors can read the full analysis on the official website of AlleAktien at the AlleAktien website.

Discover undervalued stocks with Eulerpool.

Subscribe for $2

News

From Forbes Star to Inmate: Fintech Founder Charlie Javice Must Go to Jail

She was once considered one of the greatest talents in the US financial scene – now she has been sentenced to more than seven years in prison for fraud. Charlie Javice, founder of the start-up Frank, deceived J.P. Morgan during the sale of her company with manipulated customer numbers.

Raid against far-right group – Investigators arrest 18-year-old

Police and public prosecutors have taken extensive action against the group "Deutsche Jugend voran" in Berlin, Brandenburg, and Mecklenburg-Vorpommern. The allegation: brutal attacks on journalists and political opponents.

Lufthansa stock in nosedive: Pilots vote for strike

Lufthansa shares in a tailspin: Pilots vote for strike – labor dispute threatens in the middle of the autumn holidays Lufthansa passengers must prepare for new flight cancellations: In a ballot, a large majority of pilots voted for industrial action. Now strikes threaten in the middle of the travel season – and the stock plunges by more than seven percent.

Fraport Stock: Tailwind for a Swing Trade – Will the Uptrend Hold Until November?

The Fraport share remains on the rise despite economic uncertainties and could now be on the verge of an exciting trading opportunity with a potential breakout above an important chart level.

Trump threatens Russia and insults Medvedev

In front of the assembled military leadership, the US President boasted in Quantico about America's nuclear submarine fleet, attacked Russia's former head of state Dmitry Medvedev, and once again demanded the Nobel Peace Prize—for the United States.